Leukemia cutis and neuroleukemiosis are two rare extramedullary manifestations of acute leukemia. We report a 32-year-old woman with multiple skin lesions and painful peripheral neuropathy. Bone marrow biopsy and skin biopsy confirmed the diagnosis of mixed phenotypic acute leukemia. After induction chemotherapy, she attained marrow remission, her skin lesion resolved completely, and her neurologic symptoms significantly improved. E xtramedullary manifestations are unusual clinical presentations of acute leukemia reported in 20% to 40% of patients (1) . Th ese include myeloid sarcoma, central nervous system leukemia, testicular involvement, gingival infi ltration, leukemia cutis, and neuroleukemiosis. Such manifestations may follow, precede, or occur concomitantly with the diagnosis of leukemia. We report a patient with mixed phenotypic acute leukemia who presented with two distinct concurrent extramedullary manifestations: leukemia cutis and neuroleukemiosis.
CASE PRESENTATION
A 32-year-old woman presented with painless growing violaceous plaque over her lower back. Within 3 months, she developed multiple other lesions. Additionally, she had paresthesias of the limbs in the form of numbness, pricking, and burning pain and features of distal muscle weakness. She presented to our center following a skin biopsy. Multiple welldefi ned discrete nontender indurated plaques and nodules were noted on the lower back, anterior abdominal wall, thighs, and upper limb, with the largest measuring 6 × 6 cm ( Figure  1a ). Sensation was preserved over the lesions but peripheral neuropathy was suspected due to weakness of bilateral hand and foot muscles with wasting and demonstrable distal sensory defi cits. Laboratory testing revealed a hemoglobin of 13.9 g/dL, total leukocyte count of 15,600/mm² with 14% abnormal cells, and a platelet count of 331,000/mm². Peripheral blood smear examination showed 12% blasts. Bone marrow aspirate revealed 80% blasts, and >50% were peroxidase positive (Figure 2a) . Immunophenotyping by fl ow cytometry demonstrated the blasts expressed the myeloid marker anti-MPO (strongly positive) and B-cell markers CD10, CD19, CD20, and cyCD79a. Th e other myeloid markers (CD13, CD33) and T-cell markers (cyCD3, CD3, CD5) were negative. Th is was consistent with a diagnosis of mixed phenotypic acute leukemia (B/myeloid). Th e skin biopsy displayed focal infi ltration by atypical medium to large cells around skin appendages (Figure 2b) . Th e atypical cells were CD20 positive, MPO positive, CD5 negative, and CD34 negative, compatible with acute leukemia infi ltrating the skin. Magnetic resonance imaging showed no evidence of brain parenchymal, orbital, or intraspinal deposits. Nerve conduction fi ndings were consistent with peripheral neuropathy. Cerebrospinal fl uid was normal.
Th e patient was started on chemotherapy with the hyper-CVAD regimen (cyclophosphamide, vincristine, doxorubicin, methotrexate, cytarabine, and dexamethasone). After induction, she achieved marrow remission, her skin lesions disappeared completely (Figure 1b) , and distal paraesthesia also improved. She is currently continuing treatment with additional cycles of chemotherapy.
DISCUSSION Extramedullary lesions are rare presentations of acute leukemia and often lead to diagnostic dilemmas. Several studies have found that extramedullary leukemia is associated with poor response to chemotherapy and early relapse (1, 2). Leukemia cutis is defi ned as cutaneous infi ltration by leukemic blasts that results in clinically identifi able cutaneous lesions (1) . Classically the lesions are papules, plaques, or nodules ranging from violaceous to red-brown (3). Extramedullary lesions occur most commonly in patients with acute myeloid leukemia (10%-15%) and chronic lymphocytic leukemia (4%-20%) and rarely in lymphoblastic leukemia (1%) (4) . Leukemia cutis appears to be associated with a higher percentage of extramedullary leukemic involvement at other sites, especially the central nervous system (5) . Most leukemia cutis lesions occur in the setting of an established systemic leukemia, but lesions may rarely precede bone marrow involvement, which is known as aleukemic leukemia cutis. Despite several reports of leukemia cutis with acute myeloid and lymphoid leukemia, it has only rarely been reported with mixed phenotypic acute leukemia (6) . Its presence has been suggested as a marker of aggressive disease and poor outcome. In a series of 42 patients with leukemia cutis, 37 (88%) died within 1 year of diagnosis (2) .
Neuroleukemiosis, the leukemic infiltration of peripheral nerves, is another exceedingly rare extramedullary leukemia (7) . In a series of five patients with neuroleukemiosis, all presented with painful progressive motor and sensory deficits, and three had acute myeloid leukemia while two had chronic lymphocytic leukemia (7). Leukemic infi ltration of the peripheral nerves was the initial presentation in a recent series of three patients with acute leukemia and multiple myeloma (8) . In patients with neuroleukemiosis, a nerve conduction study/electromyogram is more likely to demonstrate an axonal process. Leukemic infi ltration by tumor cells can be established by a sural nerve biopsy. Concurrent leukemia cutis and neuroleukemiosis as the initial presentation of mixed phenotypic acute leukemia, as in our patient, is extremely rare. 
